Andy C. Kiser, MD, FACS, FACC, FCCP, St. Clair’s chief of cardiac surgery, and Christopher E. Pray, MD, FACC, St. Clair’s director of medical imaging, served as Co-Directors of the Pittsburgh Heart Team Summit, which featured presentations by the country’s foremost experts in cardiology and cardiac surgery leaders. The expert presentations focused on the most progressive medical and surgical interventions for atrial fibrillation, heart valve disease, heart failure, and coronary artery disease, as well the newest technology in cardiac imaging and other topics. The faculty presented clinical evidence and practical guidelines to enhance teamwork and build alliances to advance excellence in the care of patients with cardiovascular disease.
A highlight was the keynote session, “What Does Low-Risk Transcatheter Aortic Valve Replacement (TAVR) Mean to Cardiologists and Surgeons?” presented by Michael Mack, MD, Medical Director, Cardiovascular Surgery, The Heart Hospital at Baylor Scott and White, Plano Texas. Dr. Mack, the lead author of a groundbreaking study on TAVR, announced FDA approval of TAVR for low risk patients at the Heart Team Summit; the FDA ruling expands the availability of transcatheter aortic valve replacement for patients with severe aortic stenosis.
Check back soon for sponsorship information for the 2020 Heart Team Summit.
By providing sponsorship, your company will have a unique opportunity to:
This activity is approved for AMA PRA Category 1 Credit(s)™. This activity is eligible for ANCC credit.
CME/CE Credit Provided by AKH Inc., Advancing Knowledge in Healthcare. This activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and St. Clair Hospital Foundation.